DK1283845T3 - Fremgangsmåde til fremstilling af farmaceutiske acceptable salte af (SS-RS)-S-adenosyl-L-methionin - Google Patents
Fremgangsmåde til fremstilling af farmaceutiske acceptable salte af (SS-RS)-S-adenosyl-L-methioninInfo
- Publication number
- DK1283845T3 DK1283845T3 DK01943206T DK01943206T DK1283845T3 DK 1283845 T3 DK1283845 T3 DK 1283845T3 DK 01943206 T DK01943206 T DK 01943206T DK 01943206 T DK01943206 T DK 01943206T DK 1283845 T3 DK1283845 T3 DK 1283845T3
- Authority
- DK
- Denmark
- Prior art keywords
- adenosyl
- methionine
- preparation
- pharmaceutically acceptable
- acceptable salts
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical class O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/38—Nucleosides
- C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI001158A IT1318535B1 (it) | 2000-05-25 | 2000-05-25 | Processo per la preparazione di sali farmaceuticamente accettabili di(ss,rs)-s-adenosil-l-metionina. |
| PCT/EP2001/003633 WO2001090130A1 (en) | 2000-05-25 | 2001-03-30 | Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1283845T3 true DK1283845T3 (da) | 2004-04-13 |
Family
ID=11445118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01943206T DK1283845T3 (da) | 2000-05-25 | 2001-03-30 | Fremgangsmåde til fremstilling af farmaceutiske acceptable salte af (SS-RS)-S-adenosyl-L-methionin |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20020010147A1 (https=) |
| EP (1) | EP1283845B1 (https=) |
| JP (1) | JP4777588B2 (https=) |
| KR (1) | KR100737193B1 (https=) |
| AT (1) | ATE256695T1 (https=) |
| AU (2) | AU2001265848B8 (https=) |
| CA (1) | CA2407559C (https=) |
| DE (1) | DE60101575T2 (https=) |
| DK (1) | DK1283845T3 (https=) |
| ES (1) | ES2208610T3 (https=) |
| IT (1) | IT1318535B1 (https=) |
| PT (1) | PT1283845E (https=) |
| TR (1) | TR200302297T4 (https=) |
| WO (1) | WO2001090130A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7033815B2 (en) | 2001-03-30 | 2006-04-25 | Board Of Regents, The University Of Texas System | Biosynthesis of S-adenosylmethionine in a recombinant yeast strain |
| CN100398659C (zh) * | 2002-09-16 | 2008-07-02 | 上海青瑞生物医药技术有限公司 | 旋光纯(s,s)-腺甘甲硫氨酸制备的方法 |
| US20050272687A1 (en) * | 2004-06-08 | 2005-12-08 | Hebert Rolland F | Stable S-adenosyl-l-methionine |
| US20090012036A1 (en) * | 2005-05-24 | 2009-01-08 | Hebert Rolland F | Stable S-adenosyl-L-methionine |
| ES2406412T3 (es) | 2005-06-09 | 2013-06-06 | Gnosis S.P.A. | Células de Saccharomyces cerevisiae secas, liofilizadas y/o microencapsuladas con un alto contenido de (S)-(+)-S-adenosil-metionina |
| ITRM20050344A1 (it) * | 2005-06-30 | 2007-01-01 | Luca Maria De | Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi. |
| CN1955306B (zh) * | 2005-10-28 | 2011-03-16 | 上海医药工业研究院 | 酵母菌生物合成、生产旋光纯腺苷甲硫氨酸的方法及其培养液 |
| ITMI20060629A1 (it) | 2006-03-31 | 2007-10-01 | Daniele Giovannone | Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento |
| US8202515B2 (en) | 2006-05-10 | 2012-06-19 | Mitsubishi Gas Chemical Company, Inc. | Method of producing dry yeast containing S-adenosyl-L-methionine and composition for oral intake |
| US20070265211A1 (en) * | 2006-05-12 | 2007-11-15 | Matthias Rath | Novel composition and method effective in inhibiting the atherogenic process |
| ITMI20071374A1 (it) * | 2007-07-10 | 2009-01-11 | Gnosis Spa | Sali stabili di s-adenosilmetionina e processo per il loro ottenimento. |
| US20100004191A1 (en) * | 2008-07-01 | 2010-01-07 | Rolland F Hebert | Compositions of S-adenosyl-L-methionine. |
| US9534010B2 (en) | 2013-01-16 | 2017-01-03 | Hebert Sam-E Llc | Stable indole-3-propionate salts of S-adenosyl-L-methionine |
| ITMI20130426A1 (it) * | 2013-03-20 | 2014-09-21 | Gnosis Spa | S-adenosilmetionina sterile ad alto contenuto di isomero attivo per soluzioni iniettabili e procedimento per ottenerla |
| CN106349311B (zh) * | 2016-08-23 | 2018-04-13 | 北京金阳利康医药有限公司 | 从酵母发酵液中提取s‑腺苷蛋氨酸的方法 |
| IT201700074957A1 (it) | 2017-07-04 | 2019-01-04 | Gnosis Spa | Sale di (ss)-adenosil metionina con inositolo esafosfato e procedimento per ottenerlo |
| CN110396120B (zh) * | 2019-02-13 | 2020-05-12 | 山东惠仕莱生物科技有限公司 | 一种从s-腺苷蛋氨酸发酵液中提取分离s-腺苷蛋氨酸的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE39517B1 (en) * | 1973-06-27 | 1978-10-25 | Bioresearch Sas | Double salts of s-adenosyl-l-methhionine |
| JPS56145299A (en) * | 1980-04-11 | 1981-11-11 | Kanegafuchi Chem Ind Co Ltd | Purification of s-adenosyl-l-methionine |
| JPS5929700A (ja) * | 1982-08-13 | 1984-02-16 | Nippon Zeon Co Ltd | Ｓ−アデノシル−ｌ−メチオニンの精製法 |
| IT1169773B (it) | 1983-08-24 | 1987-06-03 | Bioresearch Spa | Processo per la produzione di sali stabili della solfo-adenosil-l-metionina |
| IT1173990B (it) * | 1984-05-16 | 1987-06-24 | Bioresearch Spa | Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale |
-
2000
- 2000-05-25 IT IT2000MI001158A patent/IT1318535B1/it active
-
2001
- 2001-03-30 ES ES01943206T patent/ES2208610T3/es not_active Expired - Lifetime
- 2001-03-30 WO PCT/EP2001/003633 patent/WO2001090130A1/en not_active Ceased
- 2001-03-30 EP EP01943206A patent/EP1283845B1/en not_active Expired - Lifetime
- 2001-03-30 JP JP2001586317A patent/JP4777588B2/ja not_active Expired - Lifetime
- 2001-03-30 AT AT01943206T patent/ATE256695T1/de active
- 2001-03-30 DK DK01943206T patent/DK1283845T3/da active
- 2001-03-30 PT PT01943206T patent/PT1283845E/pt unknown
- 2001-03-30 CA CA002407559A patent/CA2407559C/en not_active Expired - Lifetime
- 2001-03-30 TR TR2003/02297T patent/TR200302297T4/xx unknown
- 2001-03-30 AU AU2001265848A patent/AU2001265848B8/en not_active Expired
- 2001-03-30 KR KR1020027015667A patent/KR100737193B1/ko not_active Expired - Lifetime
- 2001-03-30 AU AU6584801A patent/AU6584801A/xx active Pending
- 2001-03-30 DE DE60101575T patent/DE60101575T2/de not_active Expired - Lifetime
- 2001-04-11 US US09/829,906 patent/US20020010147A1/en not_active Abandoned
-
2002
- 2002-05-13 US US10/142,876 patent/US6958233B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60101575T2 (de) | 2004-06-03 |
| US20020173012A1 (en) | 2002-11-21 |
| US20020010147A1 (en) | 2002-01-24 |
| ITMI20001158A0 (it) | 2000-05-25 |
| CA2407559A1 (en) | 2001-11-29 |
| AU2001265848B8 (en) | 2006-05-04 |
| AU2001265848B2 (en) | 2006-03-23 |
| KR20030036183A (ko) | 2003-05-09 |
| PT1283845E (pt) | 2004-04-30 |
| ES2208610T3 (es) | 2004-06-16 |
| JP4777588B2 (ja) | 2011-09-21 |
| US6958233B2 (en) | 2005-10-25 |
| WO2001090130A1 (en) | 2001-11-29 |
| ATE256695T1 (de) | 2004-01-15 |
| CA2407559C (en) | 2009-12-22 |
| EP1283845B1 (en) | 2003-12-17 |
| AU6584801A (en) | 2001-12-03 |
| DE60101575D1 (de) | 2004-01-29 |
| IT1318535B1 (it) | 2003-08-27 |
| KR100737193B1 (ko) | 2007-07-10 |
| EP1283845A1 (en) | 2003-02-19 |
| ITMI20001158A1 (it) | 2001-11-25 |
| TR200302297T4 (tr) | 2004-02-23 |
| JP2003534349A (ja) | 2003-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1283845T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske acceptable salte af (SS-RS)-S-adenosyl-L-methionin | |
| DE60117289D1 (de) | Schnelllösliche tabletten | |
| BG106013A (en) | New compounds and compositions as protease inhibitors | |
| GEP20104895B (en) | Preparation of pregabalin and related compounds | |
| IS7319A (is) | Fjölgervingar klópídógrelvetnissúlfats | |
| SE0100901D0 (sv) | New composition | |
| SE9900100D0 (sv) | New compounds | |
| AP2002002637A0 (en) | Novel piperazine | |
| NO2013017I2 (no) | (a)dekstrometorfan eller et farmasøytisk akseptabelt salt derav, for eksempel dekstrometorfanhydrobromid og (b) quinidin eller etfarmasøytisk akseptabelt salt derav, for eksempel quinidinsulfat | |
| DK1301201T3 (da) | Behandling af glycogenosis type II | |
| DK1696931T3 (da) | Amino-substituerede diaryl[A,D]cyclohepten-analoger som muskarinske agonister og fremgangsmåder til behandling af neuropsykiatriske sygdomme | |
| NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| EP1767197A3 (en) | Treatment of Alzheimer's disease with inhibitors of cell cycle re-entry and progression | |
| IL145068A0 (en) | The use of glycine betaine to prepare a pharmaceutical composition | |
| BG108426A (bg) | Нови производни на сулфоновата киселина | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| TW200502231A (en) | Prodrugs of proton pump inhibitors | |
| ATE240958T1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
| EA200400530A1 (ru) | Перекрестно-сшитые антибиотики "гликопептид-цефалоспорин" | |
| ATE325135T1 (de) | 2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung | |
| EA200300272A1 (ru) | Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их | |
| PT1347984E (pt) | Processo para a preparacao de derivados de taxano | |
| BRPI0416637A (pt) | método para produção de uma solução aquosa de etanolamina de cobre e de uma solução de monoetanolamina de cobre | |
| AR027349A1 (es) | Derivados de amidas heterociclicas | |
| ATE330956T1 (de) | Bizyklisch substituierte 4- aminopyridopyrimidinderivate |